HER2 Support Group Forums - View Single Post

Becky · 10-23-2006, 04:18 PM

Jean

There is some preliminary data (done on women with bone mets) that Femara may be slightly better than Arimidex or Aromosin but not statistically better. But this is for progression of metastatic disease and in the bone only. San Antonio may tell more or we might have to wait for the trial to be done. This trial compares the 3 drugs. My cousin (who is only highly ER/PR+) is on this trial and in the Arimidex arm. I am taking Arimidex because last year, this was the only drug whose trial directly compared it to tamoxifen. At that time, Femara's trial was using it after 5 yrs of Tamoxifen and Aromosin was switching to it after 2 yrs of Tamoxifen (Arimidex also had a trial like this as well).

Kind regards

Becky

10-23-2006, 04:18 PM	#6
Becky Senior Member Join Date: Sep 2005 Location: Stockton, NJ Posts: 4,179	Jean There is some preliminary data (done on women with bone mets) that Femara may be slightly better than Arimidex or Aromosin but not statistically better. But this is for progression of metastatic disease and in the bone only. San Antonio may tell more or we might have to wait for the trial to be done. This trial compares the 3 drugs. My cousin (who is only highly ER/PR+) is on this trial and in the Arimidex arm. I am taking Arimidex because last year, this was the only drug whose trial directly compared it to tamoxifen. At that time, Femara's trial was using it after 5 yrs of Tamoxifen and Aromosin was switching to it after 2 yrs of Tamoxifen (Arimidex also had a trial like this as well). Kind regards Becky